ALLG AMLM26 Phase 1B/2 Study Investigating Novel Therapies to Target Early Relapse and Clonal Evolution As Pre-Emptive Therapy in AML (INTERCEPT): A Multi-Arm, Precision-Based, Recursive, Platform Trial

Saved in:
Bibliographic Details
Published in:Blood 2022-11, Vol.140 (Supplement 1), p.3341-3343
Main Authors: Wei, Andrew H, Iland, Harry J, Reynolds, John, Loo, Sun, Chua, Chong Chyn, Westerman, David, Tiong, Ing S, Ivey, Adam, Blombery, Piers, Anstee, Natasha S, Koldej, Rachel M, Curtis, David J., Kipp, David, Ritchie, David, Ross, David M, Souza, Amanda, Collins, Jenny, Bajel, Ashish, Grove, Carolyn, Marlton, Paula, Roberts, Andrew W, Pemmaraju, Naveen, Patel, Keyur P., Loghavi, Sanam, Konopleva, Marina, Daver, Naval, DiNardo, Courtney D.
Format: Article
Language:English
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:0006-4971
1528-0020
DOI:10.1182/blood-2022-167837